KMDA FY 2021 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$495M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$104M-22.2% YoY

Gross Profit

$30M29.3% margin

Operating Income

-$696,000-0.7% margin

Net Income

-$2M-2.2% margin

EPS (Diluted)

$-0.05

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$319M

Total Liabilities

$142M

Stockholders' Equity

$177M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$104M	$133M	-22.2%
Gross Profit	$30M	$48M	-36.2%
Operating Income	-$696,000	$19M	-103.6%
Net Income	-$2M	$17M	-113.0%